Paclitaxel alters the function of the small diameter sensory neurons

dc.contributor.advisorVasko, Michael R.
dc.contributor.authorGracias, Neilia
dc.contributor.otherBrustovetsky, Nickolay
dc.contributor.otherHingtgen, Cynthia M., 1966-
dc.contributor.otherHudmon, Andrew
dc.contributor.otherKelley, Mark Richard, 1957-
dc.date.accessioned2011-07-08T15:39:52Z
dc.date.available2011-07-08T15:39:52Z
dc.date.issued2011-07-08
dc.degree.date2011en_US
dc.degree.disciplineDepartment of Medical Neuroscienceen
dc.degree.grantorIndiana Universityen_US
dc.degree.levelPh.D.en_US
dc.descriptionIndiana University-Purdue University Indianapolis (IUPUI)en_US
dc.description.abstractAlthough paclitaxel is a commonly used anti-neoplastic agent for the treatment of solid tumors, therapy often results in a number of side effects, the most debilitating of which is peripheral neuropathy. Peripheral neuropathy is defined as a pathology of peripheral nerves, and, depending on the type of nerves damaged, the neuropathy can be classified as sensory, motor, or autonomic neuropathy. In the case of peripheral neuropathy induced by paclitaxel, the symptoms are experienced in the extremities and are sensory in nature. Patients undergoing chemotherapy with paclitaxel often report sensory disturbances such as burning, tingling, numbness, a diminished sensation to pain and temperature, loss of vibration sense, loss of proprioception, and loss of deep tendon reflexes. Electrophysiological abnormalities including decreased sensory nerve action potential amplitude and conduction confirm damage to large myelinated fibers. However, the involvement of damage to small diameter sensory neurons in the etiology of paclitaxel – induced peripheral neuropathy is still controversial. Therefore, experiments were performed to determine if paclitaxel alters the function of small diameter sensory neurons and to examine the mechanisms responsible for the change in function. vi Sensory neuron mediated vasodilatation in paclitaxel – injected animals was examined as an indirect measure of calcitonin gene related peptide (CGRP) release and therefore of sensory neuron function. CGRP release was also directly measured from central terminals in the spinal cord. To examine mechanisms of paclitaxel – induced sensory neuron damage, CGRP release and neurite length was examined in paclitaxel – treated sensory neurons in culture. The results demonstrate that (1) paclitaxel decreases the ability of small diameter sensory neurons to produce an increase in blood flow in the skin; (2) paclitaxel alters the release of CGRP from the small diameter sensory neurons; (3) paclitaxel causes the neuronal processes of isolated sensory neurons to degenerate. This dissertation provides novel information showing that paclitaxel alters the function of small diameter sensory neurons and thus provides a better understanding of the mechanisms mediating the sensory disturbances characteristic of peripheral neuropathy resulting from chemotherapy with paclitaxel.en_US
dc.identifier.urihttps://hdl.handle.net/1805/2606
dc.identifier.urihttp://dx.doi.org/10.7912/C2/2042
dc.subjectSmall diameter sensory neurons, paclitaxel, vasodilatationen_US
dc.subject.lcshPaclitaxelen_US
dc.subject.lcshSensory neuronsen_US
dc.subject.lcshBlood-vessels -- Dilatationen_US
dc.titlePaclitaxel alters the function of the small diameter sensory neuronsen_US
dc.typeThesisen
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Thesis_Neilia_Gracias.pdf
Size:
6.92 MB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.88 KB
Format:
Item-specific license agreed upon to submission
Description: